McEnany Patrick J's Form 4 filing
Catalyst Pharmaceuticals, Inc. (CPRX) · filed Sep 15, 2022
- Accession no.
- 0001161697-22-000457
- Filed
- Sep 15, 2022
- Trade date
- Sep 13-14, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $15.8M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| McEnany Patrick JCIK 0000929985 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 13, 2022 | Common stock, par value $0.001 per share | SSaleDisposed | −80,765 | $15.33F2 | −$1,238,127.45 | 4,849,452 | Direct | |
| Sep 14, 2022 | Common stock, par value $0.001 per share | SSaleDisposed | −946,846 | $15.41F3 | −$14,590,896.86 | 3,902,606 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $15.30 to $15.385 per share.
Referenced by the price of 1 transaction in Table I.
- F3
Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $15.25 to $15.71 per share.
Referenced by the price of 1 transaction in Table I.